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Abstract 
Growth hormone (GH) deficient (GHD) adults have decreased bone mass and muscle 
strength, impaired body composition, disturbed serum lipid pattern and increased morbidity 
and mortality in cardiovascular and cerebrovascular diseases. GH replacement normalizes 
most of these aberrations within the first year of treatment.  
This thesis aimed to investigate the effects of 10-15 years of GH replacement on muscle 
strength, bone mass and density, body composition, and cardiovascular risk factors. It also 
aimed to determine the effects of GH replacement in elderly patients and the importance of 
previous irradiation therapy for baseline characteristics and the treatment effects of GH.   
All patients had adult onset GHD resulting from pituitary disease, most commonly a pituitary 
tumour. Upper leg muscle strength was measured using a Kin-Com dynamometer and hand 
grip strength was measured with Grippit®, an electronic grip force instrument. Body 
composition and bone data were mainly assessed using dual-energy X-ray absorptiometry 
(DXA). Laboratory measurements were performed using conventional methods.  
After correcting for the age related decline in muscle strength, 10 years of GH replacement 
induced a sustained increase in knee flexor and extensor strength and hand grip strength. 
Fifteen years of GH replacement induced a transient decrease in body fat and sustained 
improvements of lean soft tissue and serum lipid profile. Fasting plasma glucose increased 
whereas HbA1c decreased. Sustained increases in total body and lumbar (L2-L4) spine BMC 
(bone mineral content) and BMD (bone mineral density) were seen. In the femur neck, BMC 
and BMD peaked at 7 years and then decreased toward baseline values. Men had a better 
treatment response in terms of bone parameters, but no major gender differences were seen in 
the other variables measured. Three years of GH replacement increased BMD and BMC in the 
lumbar (L2-L4) spine and femur neck in younger as well as elderly GHD patients, without 
differences in the treatment effect between the groups. Compared to non-irradiated patients, 
GHD patients previously treated with pituitary irradiation therapy displayed a more severely 
impaired cardiovascular risk profile at baseline. Both groups responded to GH replacement 
with improved body composition, bone mass and serum lipid pattern. However, more 
cardiovascular events were observed in the irradiated group.  
In conclusion, 10-15 years of GH replacement in hypopituitary adults induced sustained 
improvements in muscle strength, body composition, bone mass and serum lipid pattern. 
Elderly and younger patients showed a similar treatment response in terms of bone mass and 
density. Previous pituitary irradiation is associated with a more severely impaired 
cardiovascular risk profile, which is partly reversed by GH treatment. Men had a better 
treatment response in bone parameters than women.  
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